LUCD - Lucid Diagnostics Inc.

QQQ $ 454.82 $ 3.15 (0.69 %)

DIA $ 398.57 $ 0.08 (0.02 %)

SPY $ 530.36 $ 1.69 (0.32 %)

TLT $ 91.26 $ 0.42 (0.46 %)

GLD $ 225.37 $ -0.89 (-0.41 %)

Previous Close

$ 0.93

Open

$ 0.93

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 0.93 - $ 0.93

52 Week Range

$ 0.63 - $ 1.85

Volume

130,226

Average Volume

Market Cap

41.86M

Beta (5Y Monthly)

$ 1.26

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-13-2024	03-31-2024	10-Q
2	03-25-2024	12-31-2023	10-K
3	11-13-2023	09-30-2023	10-Q
4	08-14-2023	06-30-2023	10-Q
5	05-15-2023	03-31-2023	10-Q
6	03-14-2023	12-31-2022	10-K
7	11-14-2022	09-30-2022	10-Q
8	08-15-2022	06-30-2022	10-Q
9	05-16-2022	03-31-2022	10-Q
10	04-06-2022	12-31-2021	10-K
11	11-23-2021	09-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Cantor Fitzgerald Reiterates Overweight on...
05/15/2024 12:25:31

Cantor Fitzgerald analyst Ross Osborn reiterates Lucid Diagnostics (NASDAQ:LUCD) with a Overweight and maintains $3 price ta...

Needham Reiterates Buy on Lucid Diagnostic...
05/13/2024 15:50:49

Needham analyst Mike Matson reiterates Lucid Diagnostics (NASDAQ:LUCD) with a Buy and maintains $2.5 price target.

Lucid's Chairman And CEO Says We Strengthe...
05/13/2024 12:08:47

Lucid Diagnostics Q1 2024 Adj EPS $(0.21) ...
05/13/2024 12:03:45

Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0...

Lucid Diagnostics Says EsophaCap Device Re...
05/09/2024 12:23:10

Lucid Diagnostics Announces Peer-Reviewed ...
05/02/2024 11:54:18

EsoGuard demonstrated unprecedented early precancer detection, including 89% sensitivity at detecting short segment early preca...

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
04/30/2024 16:31:18

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
04/29/2024 20:31:14

Needham Reiterates Buy on Lucid Diagnostic...
04/12/2024 08:37:23

Needham analyst Mike Matson reiterates Lucid Diagnostics (NASDAQ:LUCD) with a Buy and maintains $2.5 price target.

Cantor Fitzgerald Maintains Overweight on ...
03/27/2024 14:05:45

Cantor Fitzgerald analyst Ross Osborn maintains Lucid Diagnostics (NASDAQ:LUCD) with a Overweight and lowers the price targe...

Needham Reiterates Buy on Lucid Diagnostic...
03/27/2024 09:20:42

Needham analyst Mike Matson reiterates Lucid Diagnostics (NASDAQ:LUCD) with a Buy and maintains $2.5 price target.

Lucid Diagnostics Q4 EPS $(0.23) Beats $(0...
03/25/2024 21:43:59

Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0...

Lucid Diagnostics Provides Business Update...
03/25/2024 21:33:22

Lucid Diagnostics had cash and cash equivalents of $18.9 million as of December 31, 2023, compared to $22.5 million as of Decem...

Earnings Scheduled For March 25, 2024
03/25/2024 09:33:46

Companies Reporting Before The Bell • Bitcoin Depot (NASDAQ:BTM) is expected to report quarterly loss at $0.08 per share on re...

Earnings Preview: Lucid Diagnostics
03/22/2024 14:01:32

Lucid Diagnostics Announces Data From The ...
03/21/2024 13:31:09

Prospective VA screening study demonstrates excellent EsoGuard sensitivity of 92.9% and negative predictive value of 98.6% comp...

Lucid Diagnostics Announces Multiple Prese...
03/20/2024 12:44:32

Lucid and collaborators will present data on three studies on EsoGuard® esophageal precancer testing and one on a new genetic c...

12 Health Care Stocks Moving In Monday's A...
02/19/2024 21:30:44

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
01/18/2024 13:05:59

Lucid Diagnostics Announces Peer-Reviewed ...
12/12/2023 13:31:27

Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical ...